Gilead Sciences (GILD) EBT Margin (2009 - 2026)
Gilead Sciences posted quarterly EBT Margin of 37.07% for Q1 2026, up 1234.0% year-on-year from 2.78% in Q1 2025, and up 41.37% on a QoQ basis from 26.22% in Q4 2025.
Gilead Sciences (GILD) has 18 years of EBT Margin data on file, last reported at 37.07% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 1234.0% year-over-year to 37.07%; the trailing twelve-month figure through Mar 2026 stood at 36.08% (up 1233.0% YoY), and the FY2025 full-year result was 33.27%, up 3087.0% from the prior year.
- EBT Margin for Q1 2026 stood at 37.07%, up from 26.22% in the prior quarter.
- Across five years, EBT Margin topped out at 46.87% in Q3 2025 and bottomed at 67.1% in Q1 2024.
- The 5-year median for EBT Margin is 26.22% (2025), against an average of 21.02%.
- The widest annual swing landed in 2024, when EBT Margin slumped 8756 bps; it then surged 9183 bps in 2025.
- A 5-year view of EBT Margin shows it stood at 27.49% in 2022, then slipped by 15 bps to 23.24% in 2023, then climbed by 23 bps to 28.63% in 2024, then declined by 8 bps to 26.22% in 2025, then soared by 41 bps to 37.07% in 2026.
- The last three EBT Margin figures came in at 37.07% (Q1 2026), 26.22% (Q4 2025), and 46.87% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 44.70% |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 24.89% |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 6.93% |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -21.49% |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 24.18% |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 37.07% |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 135.53% |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 28.20% |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.07% |
| Dec 31, 2025 | 26.22% |
| Sep 30, 2025 | 46.87% |
| Jun 30, 2025 | 34.30% |
| Mar 31, 2025 | 24.73% |
| Dec 31, 2024 | 28.63% |
| Sep 30, 2024 | 12.67% |
| Jun 30, 2024 | 29.52% |
| Mar 31, 2024 | -67.10% |
| Dec 31, 2023 | 23.24% |
| Sep 30, 2023 | 32.87% |
| Jun 30, 2023 | 24.06% |
| Mar 31, 2023 | 20.47% |
| Dec 31, 2022 | 27.49% |
| Sep 30, 2022 | 34.54% |
| Jun 30, 2022 | 24.01% |
| Mar 31, 2022 | -2.31% |
| Dec 31, 2021 | 10.48% |
| Sep 30, 2021 | 46.33% |
| Jun 30, 2021 | 29.23% |
| Mar 31, 2021 | 35.25% |
| Dec 31, 2020 | 24.44% |
| Sep 30, 2020 | 12.54% |
| Jun 30, 2020 | -57.81% |
| Mar 31, 2020 | 36.10% |
| Dec 31, 2019 | 32.34% |
| Sep 30, 2019 | -26.78% |
| Jun 30, 2019 | 42.39% |
| Mar 31, 2019 | 44.50% |
| Dec 31, 2018 | 17.53% |
| Sep 30, 2018 | 47.61% |
| Jun 30, 2018 | 36.93% |
| Mar 31, 2018 | 39.96% |
| Dec 31, 2017 | 35.74% |
| Sep 30, 2017 | 56.37% |
| Jun 30, 2017 | 57.62% |
| Mar 31, 2017 | 55.60% |
| Dec 31, 2016 | 53.55% |
| Sep 30, 2016 | 57.01% |
| Jun 30, 2016 | 56.57% |
| Mar 31, 2016 | 57.76% |
| Dec 31, 2015 | 63.92% |
| Sep 30, 2015 | 65.97% |
| Jun 30, 2015 | 66.85% |
| Mar 31, 2015 | 68.99% |
| Dec 31, 2014 | 57.83% |
| Sep 30, 2014 | 55.79% |
| Jun 30, 2014 | 65.89% |
| Mar 31, 2014 | 58.99% |
| Dec 31, 2013 | 35.66% |
| Sep 30, 2013 | 38.80% |
| Jun 30, 2013 | 38.87% |
| Mar 31, 2013 | 37.13% |
| Dec 31, 2012 | 39.50% |
| Sep 30, 2012 | 39.19% |
| Jun 30, 2012 | 40.31% |
| Mar 31, 2012 | 29.30% |
| Dec 31, 2011 | 37.21% |
| Sep 30, 2011 | 45.95% |
| Jun 30, 2011 | 45.97% |
| Mar 31, 2011 | 45.41% |
| Dec 31, 2010 | 40.00% |
| Sep 30, 2010 | 49.60% |
| Jun 30, 2010 | 51.53% |
| Mar 31, 2010 | 55.60% |
| Dec 31, 2009 | 52.13% |
| Sep 30, 2009 | 49.47% |
| Jun 30, 2009 | 45.87% |
| Mar 31, 2009 | 52.00% |